Literature DB >> 6324345

Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

M G Sarngadharan, M Popovic, L Bruch, J Schüpbach, R C Gallo.   

Abstract

In cats, infection with T-lymphotropic retroviruses can cause T-cell proliferation and leukemia or T-cell depletion and immunosuppression. In humans, some highly T4 tropic retroviruses called HTLV-I can cause T-cell proliferation and leukemia. The subgroup HTLV-II also induces T-cell proliferation in vitro, but its role in disease is unclear. Viruses of a third subgroup of human T-lymphotropic retroviruses, collectively designated HTLV-III, have been isolated from cultured cells of 48 patients with acquired immunodeficiency syndrome (AIDS). The biological properties of HTLV-III and immunological analyses of its proteins show that this virus is a member of the HTLV family, and that it is more closely related to HTLV-II than to HTLV-I. Serum samples from 88 percent of patients with AIDS and from 79 percent of homosexual men with signs and symptoms that frequently precede AIDS, but from less than 1 percent of heterosexual subjects, have antibodies reactive against antigens of HTLV-III. The major immune reactivity appears to be directed against p41, the presumed envelope antigen of the virus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324345     DOI: 10.1126/science.6324345

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  230 in total

1.  The safety of blood transfusions.

Authors:  M L Schroeder; H L Rayner
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

Review 2.  Why clinical trials of AIDS vaccines are premature.

Authors:  W K Mariner
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

3.  Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector.

Authors:  D Rekosh; A Nygren; P Flodby; M L Hammarskjöld; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.

Authors:  B D Walker; M Kowalski; W C Goh; K Kozarsky; M Krieger; C Rosen; L Rohrschneider; W A Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Ophthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective study.

Authors:  R C Humphry; J N Weber; R J Marsh
Journal:  Br J Ophthalmol       Date:  1987-08       Impact factor: 4.638

6.  Human immunodeficiency virus and related retroviruses.

Authors:  R Nájera; M I Herrera; R de Andrés
Journal:  West J Med       Date:  1987-12

7.  The incidence of human immunodeficiency virus (HIV) in fetal cord samples utilized as serum supplements for in vitro fertilization.

Authors:  M D Damewood; J S Hesla; W D Schlaff; M Hubbard; J T Repke; J A Rock
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

8.  AIDS as immune system activation: a model for pathogenesis.

Authors:  M S Ascher; H W Sheppard
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

Review 9.  The molecular structure of human antibodies specific for the human immunodeficiency virus.

Authors:  J S Andris; J D Capra
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

10.  Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells.

Authors:  T Kato; A Hirano; J F Llena; H M Dembitzer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.